
Care Loop Health is transforming mental healthcare through predictive software that helps prevent crises in individuals with severe mental illnesses. Their digital products, co-designed with patients and clinicians, accurately predict early warning signs for conditions like psychosis and postnatal depression, enabling timely interventions. The company leverages AI-powered predictions to enhance care personalization and improve long-term outcomes, thereby reducing the need for inpatient admissions. With a strong foundation in clinical and technical expertise, Care Loop Health is positioned as a leader in digital therapeutics for mental health, validated through rigorous research and trials.

Care Loop Health is transforming mental healthcare through predictive software that helps prevent crises in individuals with severe mental illnesses. Their digital products, co-designed with patients and clinicians, accurately predict early warning signs for conditions like psychosis and postnatal depression, enabling timely interventions. The company leverages AI-powered predictions to enhance care personalization and improve long-term outcomes, thereby reducing the need for inpatient admissions. With a strong foundation in clinical and technical expertise, Care Loop Health is positioned as a leader in digital therapeutics for mental health, validated through rigorous research and trials.
Headquarters: Manchester, United Kingdom
Founded / Launch: Circa 2021 (University of Manchester spinout)
Employees: 8
Product: AI-driven platform to predict and prevent mental health crises (B2B SaaS)
Recent funding: Seed round announced Jan 30, 2025
Predicting and preventing mental health crises for individuals with severe mental illness; care pathway integration and personalized support.
2021
Digital health; Mental health; Digital therapeutics
Other participating investors listed: Praetura Ventures, SFC Capital, Johnson & Johnson Impact Ventures
“Combination of specialist healthtech fund (Verge HealthTech Fund), regional VCs (Praetura Ventures, SFC Capital) and a corporate impact investor (Johnson & Johnson Impact Ventures)”